Please make JavaScript on and see this site.

Font size

Pmda - Pharmaceuticals and Medical Devices Agency

Menu

Close

Safety Alert & Recalls/ Review Reports/ Package Inserts etc.

Formats DL

About PMDA

About PMDA

Formats DL

Safety Alert & Recalls/ Review Reports/ Package Inserts etc.

Back

Back

For Regulatory Authorities
Regulations & Services of PMDA
Information about Approved Products in Japan
Safety Information
Advanced Efforts
FAQ
- Frequently Asked Questions (FAQ)
For Healthcare Professionals
Information for approved products in Japan
Safety information
FAQ
- Frequently Asked Questions (FAQ)
For Academia
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
- The Science Board
FAQ
- Frequently Asked Questions (FAQ)
For Business
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
- Master File System
- Accreditation of Foreign Manufacturers
Advanced efforts
FAQ
- Frequently Asked Questions (FAQ)

Back

Drugs
Regulations and Services of PMDA
Information for apporoved products in Japan
- New drugs
Safety information
Procedures in Japan
- Master File System
- Accreditation of Foreign Manufacturers
Advanced efforts
Medical devices
Regulations and Services of PMDA
Information for apporoved products in Japan
- New devices
Safety information
- PMDA Medical Safety Information
Procedures in Japan
- Accreditation of Foreign Manufacturers
Advanced efforts
Quasi-drugs
Reviews and Related Services
Regulatory Procedures
- Accreditation of Foreign Manufacturers
Post-marketing Safety Measures
- Outline of Post-marketing Safety Measures
Regenerative medical products
Reviews and Related Services
Post-marketing Safety Measures
- Outline of Post-marketing Safety Measures
Advanced Efforts
- CPC (Cell Processing Center) Subcommittee
- Cellular and Tissue-based Products Subcommittee

Home
Regulatory Science/The Science Board/Standard Development
Regulatory Science Coordination
Measures for advanced science and technology
Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning
The 3rd Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning

Regulatory Science/The Science Board/Standard Development

The 3rd Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning

日本語ページはこちら

Press Release

December 5, 2022 from 3pm to 5pm
Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

Agenda

Lectures on Software as a Medical Device Utilizing AI and Machine Learning and Discussion
- Legal issues on establishment of medical/healthcare database
  Keiji Tonomura, Partner at Nagashima Ohno & Tsunematsu (Member of the Subcommittee)
Plan in Draft
Others

List of Handouts

Document 1 Summary of Discussions at the 2nd Working Group
Document 2 Lecture Materials by Dr.Tonomura
Document 3 Contents of Draft Report

Minutes

Minutes of the 3rd Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning (in Japanese)【PDF:444KB】